I was also gripped by Ian McEwan’s What We Can Know (Cape, £22) – a philosophical novel masquerading as a bizarre dystopia of ...

EXCLUSIVE: The 1962 song “Monster Mash,” which has become an annual Halloween seasonal hit, is becoming an animated movie at Miramax. Miramax CEO Jonathan Glickman, who has been behind such haunted ...

Novo Nordisk has struck a deal to buy Akero Therapeutics for up to $5.2 billion, teeing up a showdown with Roche and others in a blockbuster liver disease market. Akero confirmed its status as a key ...

A bogus taxi driver has been convicted of abducting and sexually assaulting a woman. Mahmoud Kalawizada, 32, touched the woman's thigh and demanded she carry out a sex act on him during a journey from ...

The driver of an out-of-control taxi was critically injured when he hopped a curb and slammed into a pole just steps from the Chinese consulate in Manhattan on Thursday, police said. Three others were ...

Metabolic-associated steatohepatitis (MASH) happens when excess fat in the liver causes inflammation and scarring, or fibrosis. The condition is serious, and when left untreated it can lead to ...

Quentin Tarantino, the director of 'Pulp Fiction and 'Once Upon a Time in Hollywood', reveals some of the movies he considers to be the greatest of all time.

Roche has scooped up 89bio and its phase III FGF21 analogue pegozafermin, as drug developers continue to race to advance new drugs for the liver disease metabolic dysfunction-associated ...

A Baltimore jury ruled Friday in favor of a woman who was wounded after climbing out of a moving taxi’s window, finding that her injuries stemmed from the driver falsely imprisoning her in the cab.

Several noninvasive tests (NITs) used in patients with metabolic dysfunction-associated steatohepatitis (MASH) treated with semaglutide for 72 weeks showed significant reductions in relevant ...

If developing drugs for metabolic dysfunction-associated steatohepatitis (MASH) were a poker game, you could say Novo Nordisk (NASDAQ Copenhagen: NOVO-B) saw a competitor’s bet and raised the stakes ...

MASLD, affecting 30% of adults, is driven by obesity and insulin resistance, leading to severe liver conditions if untreated. GLP-1 RAs, such as liraglutide and semaglutide, show strong evidence for ...